LobbyingSpinal Stabilization Technologies lobbying by quarter
Spinal Stabilization Technologies's latest lobbying report covers Q2 2026, at $40K. Its first report covers Q1 2026; the issues it reports most are Budget/Appropriations and Defense.
Spinal Stabilization Technologies
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $60K
- Last 3 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2026 | $20K | 1 |
| Q2 2026 | $40K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$15K · 2 reports
- Defense$15K · 2 reports
- Health issues$15K · 2 reports
- Medical research and clinical labs$15K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Winning Strategies Washington | $60K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRYAN RICKER | Regional Director, Sen. Crapo | Q2 2026 |
| CHARLA PENN | LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd | Q2 2026 |
| CHELSEY PENROD HICKMAN | CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig | Q2 2026 |
| ELIZABETH CONNOLLY | Assistant Director of Public Health, Office of National Drug Control Policy | Q2 2026 |
| MICHAEL A MEROLA | Deputy CoS, Sen. Torricelli | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/16for Q2 | Winning Strategies Washington | $40K |
| 04/18for Q1 | Winning Strategies Washington | $20K |
| 04/03for Q1 | Winning Strategies Washington | Under $5,000 |